drugset / Trial / NCT02552537
iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions
Phase 4
Completed
44 enrolled
University of Zurich
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · collabHospital San Carlos, Madrid · collabRegion Hovedstadens Apotek · collabUniversity of Manchester · collabUniversity of Nebraska Lincoln · collab
RandomizedCrossoverDouble-blindDiagnostic
Summary
In patients with a walnut allergy double blind placebo controlled food challenge with walnut will be combined with the intake of proton pump inhibitor (PPI) or with placebo to assess the impact of PPI on threshold level and on clinical manifestation.
Timeline
- Start
- 2015-09
- Primary completion
- 2017-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omeprazole | Other / unclassified | 40 mg | — |